Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 4, 2025

Total Value: $211M (100.0% shares, 0.0% debt)

Holdings (36)

LLY ELI LILLY & CO 13.6%
Value $28.68M Shares 37,068 Est. Cost $699.44 Unrealized +17.4%
UNH UNITEDHEALTH GROUP INC 8.5%
Value $17.88M Shares 35,202 Est. Cost $502.95 Unrealized +9.9%
ABBV ABBVIE INC 7.6%
Value $15.99M Shares 90,723 Est. Cost $165.02 Unrealized +7.5%
BSX BOSTON SCIENTIFIC CORP 6.6%
Value $13.83M Shares 154,222 Est. Cost $68.73 Unrealized +28.1%
TMO THERMO FISHER SCIENTIFIC INC 6.1%
Value $12.92M Shares 24,896 Est. Cost $526.93 Unrealized +3.9%
MRK MERCK & CO INC 4.9%
Value $10.4M Shares 105,727 Est. Cost $108.20 Unrealized -8.8%
SYK STRYKER CORPORATION 4.4%
Value $9.296M Shares 25,660 Est. Cost $307.25 Unrealized +19.2%
NBIX NEUROCRINE BIOSCIENCES INC 4.4%
Value $9.288M Shares 67,763 Est. Cost $133.32 Unrealized -7.2%
ALKS ALKERMES PLC 3.6%
Value $7.67M Shares 266,499 Est. Cost $26.35 Unrealized +9.1%
VRTX VERTEX PHARMACEUTICALS INC 3.6%
Value $7.596M Shares 22,257 Est. Cost $416.73 Unrealized +11.2%
COR CENCORA INC 3.5%
Value $7.315M Shares 32,553 Est. Cost $208.00 Unrealized +12.1%
AMGN AMGEN INC 3.4%
Value $7.108M Shares 27,414 Est. Cost $267.21 Unrealized +7.1%
INTRA-CELLULAR THERAPIES INC 2.8%
Value $5.939M Shares 71,138 Est. Cost $71.76 Unrealized
EW EDWARDS LIFESCIENCES CORP 2.4%
Value $5.07M Shares 68,296 Est. Cost $73.91 Unrealized -5.3%
MIRM MIRUM PHARMACEUTICALS INC 2.3%
Value $4.805M Shares 116,692 Est. Cost $33.15 Unrealized +25.7%
DXCM DEXCOM INC 2.2%
Value $4.684M Shares 60,057 Est. Cost $99.35 Unrealized -25.5%
HRMY HARMONY BIOSCIENCES HLDGS IN 1.9%
Value $4.104M Shares 120,501 Est. Cost $33.61 Unrealized +2.2%
CAH CARDINAL HEALTH INC 1.7%
Value $3.618M Shares 30,680 Est. Cost $68.32 Unrealized +68.0%
NAMS NEWAMSTERDAM PHARMA COMPANY 1.7%
Value $3.558M Shares 138,983 Est. Cost $18.84 Unrealized +12.7%
ACLX ARCELLX INC 1.6%
Value $3.296M Shares 42,071 Est. Cost $59.65 Unrealized +44.8%
UFPT UFP TECHNOLOGIES INC 1.5%
Value $3.165M Shares 23,159 Est. Cost $282.30 Unrealized +3.1%
FOLD AMICUS THERAPEUTICS INC 1.5%
Value $3.076M Shares 326,840 Est. Cost $11.55 Unrealized -10.0%
BBIO BRIDGEBIO PHARMA INC 1.3%
Value $2.815M Shares 103,032 Est. Cost $27.97 Unrealized -7.6%
RVMD REVOLUTION MEDICINES INC 1.3%
Value $2.683M Shares 62,161 Est. Cost $50.47 Unrealized 0.0%
MERUS N V 1.2%
Value $2.619M Shares 62,521 Est. Cost $40.60 Unrealized
JANX JANUX THERAPEUTICS INC 1.0%
Value $2.078M Shares 39,573 Est. Cost $52.89 Unrealized 0.0%
ONC BEIGENE LTD 1.0%
Value $2.004M Shares 10,900 Est. Cost $183.81 Unrealized
KRYS KRYSTAL BIOTECH INC 0.7%
Value $1.47M Shares 9,202 Est. Cost $130.58 Unrealized +35.9%
MREO MEREO BIOPHARMA GROUP PLC 0.7%
Value $1.373M Shares 390,000 Est. Cost $3.82 Unrealized
SMMT SUMMIT THERAPEUTICS INC 0.6%
Value $1.315M Shares 101,177 Est. Cost $14.79 Unrealized +31.0%
CRBP CORBUS PHARMACEUTICALS HLDGS 0.6%
Value $1.188M Shares 98,304 Est. Cost $30.77 Unrealized -45.5%
AUTL AUTOLUS THERAPEUTICS PLC 0.5%
Value $1.06M Shares 479,644 Est. Cost $4.04 Unrealized
SLNO SOLENO THERAPEUTICS INC 0.5%
Value $985K Shares 30,940 Est. Cost $48.45 Unrealized +6.9%
MERSANA THERAPEUTICS INC 0.4%
Value $765K Shares 538,621 Est. Cost $2.39 Unrealized
PHVS PHARVARIS N V 0.3%
Value $653K Shares 34,328 Est. Cost $20.35 Unrealized +1.2%
CABA CABALETTA BIO INC 0.3%
Value $554K Shares 247,454 Est. Cost $8.81 Unrealized -60.1%